Nisha Singh

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Shuo Feng, Daniel J. Phillips, Thomas White et al. · Nature Medicine · 2021 · 1.2K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

Amy Ross-Russell, Nisha Singh · Oxford University Research Archive (ORA) (University of Oxford) · 2020 · 1.2K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2021 · 1.2K citations · Full text

Veterinary Medicine, Immunology, Immunization +16

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

Xinxue Liu, R. H. Shaw, Arabella Stuart et al. · The Lancet · 2021 · 545 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17